62 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

LILY34

Eli Lilly
US$125.90-1.8%99.1%US$654.2bUS$140.98PE124.8xE27.2%0.7%

N1VO34

Novo Nordisk
kr.79.84-0.2%53.0%kr.3.9tkr.83.34PE46.2xE14.8%1.1%

JNJB34

Johnson & Johnson
US$51.111.5%-7.0%US$356.4bUS$59.62PE18.6xE4.9%3.2%

MRCK34

Merck
US$81.752.0%13.8%US$318.6bUS$89.42PE872.9xE25.9%2.4%

ABBV34

AbbVie
US$54.084.5%5.9%US$294.7bUS$59.84PE61.1xE23.4%3.7%

A1ZN34

AstraZeneca
UK£59.100.4%-6.0%UK£169.7bUK£70.59PE35.3xE16.4%2.1%

TMOS34

Thermo Fisher Scientific
US$58.98-2.0%-0.7%US$208.0bUS$65.97PE34.7xE10.6%0.3%

N1VS34

Novartis
CHF49.012.4%-1.3%CHF187.3bCHF55.33PE24xE9.5%3.8%

DHER34

Danaher
US$43.72-0.3%-1.1%US$174.4bUS$49.17PE41.5xE11.3%0.4%

PFIZ34

Pfizer
US$33.952.3%-32.4%US$147.2bUS$41.29PE69xE22.1%6.5%

AMGN34

Amgen
US$49.721.6%12.8%US$144.2bUS$55.51PE21.5xE8.9%3.3%

VRTX34

Vertex Pharmaceuticals
US$510.811.3%23.1%US$101.9bUS$596.40PE28.2xE11.5%n/a

BMYB34

Bristol-Myers Squibb
US$253.00-4.5%-28.5%US$97.9bUS$291.24PE12.4xE8.3%4.9%

REGN34

Regeneron Pharmaceuticals
US$78.721.5%16.5%US$96.1bUS$90.91PE24.4xE10.9%n/a

GILD34

Gilead Sciences
US$172.30-0.9%-19.2%US$83.2bUS$220.02PE14.7xE10.0%4.6%

G1SK34

GSK
UK£42.001.2%13.7%UK£65.3bUK£52.68PE13.3xE9.4%3.6%

Z1TS34

Zoetis
US$47.55-0.5%-14.1%US$66.9bUS$70.86PE28.6xE8.1%1.2%

S1GE34

Seagen
US$56.706.7%n/aUS$43.2bUS$56.74PS18.8xE71.8%n/a

I1QV34

IQVIA Holdings
US$315.890%23.4%US$41.4bUS$382.80PE30.5xE12.7%0%

TAKP34

Takeda Pharmaceutical
JP¥69.231.0%-17.2%JP¥6.4tJP¥81.50PE35.8xE19.2%4.6%

M1RN34

Moderna
US$26.22-3.6%-26.4%US$38.8bUS$34.72PS5.7xE56.0%n/a

A1GI34

Agilent Technologies
US$346.075.4%n/aUS$38.8bUS$391.41PE31.5xE9.0%0.7%

BIIB34

Biogen
US$175.140%n/aUS$27.7bUS$268.33PE23.9xE18.2%n/a

W2ST34

West Pharmaceutical Services
US$54.800%7.5%US$27.2bUS$57.53PE45.9xE8.3%0.2%
Page 1 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.